Bernd Eisele
Director Ejecutivo en Vakzine Projekt Management GmbH .
Perfil
Bernd Eisele is the CEO of Vakzine Projekt Management GmbH since 2014.
Prior to this, he worked as the Director-International Products at Abbott Products GmbH.
He also worked as a Project Manager-Clinical at Behringwerke AG from 1988 to 1996.
Dr. Eisele holds a doctorate degree from Ruprecht-Karls-Universität Heidelberg, which he received in 1986.
Cargos activos de Bernd Eisele
| Empresas | Cargo | Inicio |
|---|---|---|
Vakzine Projekt Management GmbH
 Vakzine Projekt Management GmbH Pharmaceuticals: MajorHealth Technology Vakzine Projekt Management GmbH develops vaccines and biopharmaceuticals products from laboratory stages through to clinical examination. It offers VPM2001 vaccine to prevent human cytomegalovirus infections and VPM5001 Soluferon vaccine, treatment for multiple sclerosis (MS) and hepatitis C. The company was founded in August 2002 and is headquartered in Hannover, Germany. | Director Ejecutivo | 16/11/2009 |
Antiguos cargos conocidos de Bernd Eisele.
| Empresas | Cargo | Fin |
|---|---|---|
Behringwerke AG
 Behringwerke AG Pharmaceuticals: OtherHealth Technology Part of Sanofi, Behringwerke AG is a German company that produces specialty chemicals and pharmaceutical products. The company is based in Marburg, Germany. | Corporate Officer/Principal | 01/01/1996 |
| Abbott Products GmbH | Corporate Officer/Principal | - |
Formación de Bernd Eisele.
| Ruprecht-Karls-Universität Heidelberg | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 3 |
|---|---|
Behringwerke AG
Behringwerke AG Pharmaceuticals: OtherHealth Technology Part of Sanofi, Behringwerke AG is a German company that produces specialty chemicals and pharmaceutical products. The company is based in Marburg, Germany. | Health Technology |
Vakzine Projekt Management GmbH
Vakzine Projekt Management GmbH Pharmaceuticals: MajorHealth Technology Vakzine Projekt Management GmbH develops vaccines and biopharmaceuticals products from laboratory stages through to clinical examination. It offers VPM2001 vaccine to prevent human cytomegalovirus infections and VPM5001 Soluferon vaccine, treatment for multiple sclerosis (MS) and hepatitis C. The company was founded in August 2002 and is headquartered in Hannover, Germany. | Health Technology |
| Abbott Products GmbH |
- Bolsa de valores
- Insiders
- Bernd Eisele
